↓ Skip to main content

Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients

Overview of attention for article published in BMC Nephrology, February 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients
Published in
BMC Nephrology, February 2014
DOI 10.1186/1471-2369-15-27
Pubmed ID
Authors

Myriam Lessard, Denis Ouimet, Martine Leblanc, Annie-Claire Nadeau-Fredette, Robert Bell, Jean-Philippe Lafrance, Vincent Pichette, Michel Vallée

Abstract

Activated vitamin D is the mainstay of treatment for secondary hyperparathyroidism (SHPT) in chronic hemodialysis patients. However, the optimal route of administration is still debated. The aim of our study was to compare efficacy of oral vs intravenous (IV) administration of alfacalcidol in hemodialysis. A secondary objective was to determine the cost-effectiveness advantage of oral administration.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Denmark 1 3%
Egypt 1 3%
Unknown 29 91%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 19%
Researcher 6 19%
Student > Bachelor 4 13%
Student > Postgraduate 3 9%
Other 2 6%
Other 5 16%
Unknown 6 19%
Readers by discipline Count As %
Medicine and Dentistry 7 22%
Pharmacology, Toxicology and Pharmaceutical Science 5 16%
Nursing and Health Professions 3 9%
Computer Science 2 6%
Unspecified 1 3%
Other 7 22%
Unknown 7 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2014.
All research outputs
#6,402,089
of 22,743,667 outputs
Outputs from BMC Nephrology
#687
of 2,461 outputs
Outputs of similar age
#76,585
of 307,189 outputs
Outputs of similar age from BMC Nephrology
#17
of 51 outputs
Altmetric has tracked 22,743,667 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 2,461 research outputs from this source. They receive a mean Attention Score of 4.7. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,189 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.